Zobrazeno 1 - 10
of 86
pro vyhledávání: '"J. Lopez Diaz"'
Autor:
Bettina J Lehman, Fernando J Lopez-Diaz, Thom P Santisakultarm, Linjing Fang, Maxim N Shokhirev, Kenneth E Diffenderfer, Uri Manor, Beverly M Emerson
Publikováno v:
PLoS Genetics, Vol 17, Iss 1, p e1009277 (2021)
The nuclear protein CCCTC-binding factor (CTCF) has diverse roles in chromatin architecture and gene regulation. Functionally, CTCF associates with thousands of genomic sites and interacts with proteins, such as cohesin, or non-coding RNAs to facilit
Externí odkaz:
https://doaj.org/article/885202f5c4b9446984f6463da2b4e510
Autor:
Hatim Husain, Scott M. Lippman, Fernando J. Lopez-Diaz, Brian D. Woodward, Parissa Keshavarzian, John Paul Shen, Ajaz Bulbul, Ayesha Murtuza
EGFR-activating mutations are observed in approximately 15% to 20% of patients with non–small cell lung cancer. Tyrosine kinase inhibitors have provided an illustrative example of the successes in targeting oncogene addiction in cancer and the role
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5880488cbc28057784b3cc4ee360618d
https://doi.org/10.1158/0008-5472.c.6511314.v1
https://doi.org/10.1158/0008-5472.c.6511314.v1
Autor:
Hatim Husain, Scott M. Lippman, Fernando J. Lopez-Diaz, Brian D. Woodward, Parissa Keshavarzian, John Paul Shen, Ajaz Bulbul, Ayesha Murtuza
Clinical Outcomes with Various Third Generation EGFR Inhibitors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be7527af240419c04540e2f8d58e74ed
https://doi.org/10.1158/0008-5472.22422693.v1
https://doi.org/10.1158/0008-5472.22422693.v1
Autor:
Hatim Husain, Scott M. Lippman, Fernando J. Lopez-Diaz, Brian D. Woodward, Parissa Keshavarzian, John Paul Shen, Ajaz Bulbul, Ayesha Murtuza
Chemical Structures of Third Generation Anti-EGFR Compounds
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fde5c4078b1738b7f01e4a9f530ae4f
https://doi.org/10.1158/0008-5472.22422696
https://doi.org/10.1158/0008-5472.22422696
Autor:
Hatim Husain, Scott M. Lippman, Fernando J. Lopez-Diaz, Brian D. Woodward, Parissa Keshavarzian, John Paul Shen, Ajaz Bulbul, Ayesha Murtuza
EGFR Receptor Signaling and Bypass Pathways
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::543b85e8a4e4afc98b305d22f682a0bd
https://doi.org/10.1158/0008-5472.22422699
https://doi.org/10.1158/0008-5472.22422699
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Abstract 219: Single-tube NGS profiling allows identification of molecular signature in ALL patients
Autor:
Lina Zelinger, Samuel Koo, Charmeine Ko, Francys Alarcon, Kenneth B. Thomas, Segun C. Jung, Fernando J. Lopez Diaz, Fei Ye, Shashikant Kulkarni
Publikováno v:
Cancer Research. 83:219-219
Background: Acute lymphoblastic leukemia (ALL) can be classified to subtypes by molecular signatures correlating to prognosis and treatment regimen, making accurate molecular profiling of interest for both clinical and research communities. NGS techn
Autor:
A Jeronimo, C Olmos, C N Perez-Garcia, C Ferrera Duran, P E Garcia-Granja, J Lopez Diaz, C Saez Bejar, C Sarria Cepeda, M C Alcazar, A San Roman, I Vilacosta
Publikováno v:
European Heart Journal. 42
Background Although Candida albicans is the most frequent microorganism causing fungal endocarditis, its incidence has decreased during the last two decades, and that of non-albicans Candida species has risen. Among the last, Candida parapsilosis is
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Fernando J. Lopez-Diaz, Rachel Schell, Chaugiang Duong, Steven Rivera, Vincent Anthony Funari
Publikováno v:
Journal of Clinical Oncology. 40:e18804-e18804
e18804 Background: More frequently, select gene fusions have been tested in clinical practice as more approvals of very effective therapies targeting oncogenic chimeric fusion proteins. Large studies based on DNA-based NGS testing alongside clinical